• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏瓣膜疾病患者和人工心脏瓣膜患者血浆中的β-血小板球蛋白(作者译)

[beta-Thromboglobulin in plasma in patients with heart-valve diseases and with prosthetic heart valves (author's transl)].

作者信息

Heilmann E, Bender F, Breuer H W, Klinke F

出版信息

Z Kardiol. 1980 Dec;69(12):815-7.

PMID:6169213
Abstract

In each 50 patients with rheumatic heart valve diseases and after implantation of prosthetic heart valves and in 20 patients with bioprostheses, beta-thromboglobulin (beta-TG) in plasma was determined. In all cases beta-TG was significantly elevated above the normal range. The levels of beta-TG lay in patients with bioprostheses lower than in the other groups. Bioprostheses are less damaging the thrombocytes than prosthetic heart valves.

摘要

在50例风湿性心脏瓣膜病患者人工心脏瓣膜植入术后以及20例使用生物瓣膜的患者中,测定了血浆中的β-血小板球蛋白(β-TG)。在所有病例中,β-TG均显著高于正常范围。使用生物瓣膜患者的β-TG水平低于其他组。与人工心脏瓣膜相比,生物瓣膜对血小板的损伤较小。

相似文献

1
[beta-Thromboglobulin in plasma in patients with heart-valve diseases and with prosthetic heart valves (author's transl)].心脏瓣膜疾病患者和人工心脏瓣膜患者血浆中的β-血小板球蛋白(作者译)
Z Kardiol. 1980 Dec;69(12):815-7.
2
[Changes in serum beta-thromboglobulin levels during oral contraception, cardiac valve disease and pulmonary embolism (author's transl)].口服避孕药、心脏瓣膜病和肺栓塞期间血清β-血小板球蛋白水平的变化(作者译)
Nouv Presse Med. 1981 Apr 11;10(16):1327-9.
3
[Effect of the degree of anticoagulation on the plasma levels of beta-thromboglobulin in patients with heart valve prostheses treated with warfarin].[华法林治疗的心脏瓣膜置换患者抗凝程度对血浆β-血小板球蛋白水平的影响]
Minerva Cardioangiol. 1984 Jun;32(6):387-91.
4
Late incidence and determinants of reoperation in patients with prosthetic heart valves.人工心脏瓣膜置换术后再次手术的晚期发生率及影响因素
Eur J Cardiothorac Surg. 2004 Mar;25(3):364-70. doi: 10.1016/j.ejcts.2003.12.013.
5
beta-Thromboglobulin--a specific marker of in-vivo platelet release reaction.
Thromb Haemost. 1980 Aug 29;44(1):23-9.
6
[Heart valve replacement in the treatment of rheumatic valvular diseases (author's transl)].
Zhonghua Wai Ke Za Zhi. 1979;17(2):88-91.
7
Plasma concentration of platelet-specific proteins and fibrinopeptide A in patients with artificial heart valves.
Haemostasis. 1981;10(4):186-94. doi: 10.1159/000214403.
8
[Structural changes of Hancock bioprostheses in children (author's transl)].儿童汉考克生物假体的结构变化(作者译)
G Ital Cardiol. 1980;10(11):1520-5.
9
Aortic valve replacement in patients aged 50 to 70 years: improved outcome with mechanical versus biologic prostheses.50至70岁患者的主动脉瓣置换术:机械瓣膜与生物瓣膜相比,预后改善
J Thorac Cardiovasc Surg. 2008 Apr;135(4):878-84; discussion 884. doi: 10.1016/j.jtcvs.2007.10.065. Epub 2008 Mar 4.
10
Platelet and coagulation function in patients with abnormal cardiac valves treated with sulphinpyrazone.用磺吡酮治疗的心脏瓣膜异常患者的血小板及凝血功能
Thromb Haemost. 1981 Dec 23;46(4):743-6.

引用本文的文献

1
A study of embolism in mitral valve disease and atrial fibrillation.二尖瓣疾病和心房颤动中栓塞的研究。
Br Heart J. 1983 Feb;49(2):133-40. doi: 10.1136/hrt.49.2.133.